APAnusch Peyman
Anusch Peyman
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anusch Peyman has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Jochen Knolle
Aventis Pharma Deutschland GmbH, D-65926 Frankfurt, Germany
3 shared publicationsThomas R. Gadek
Genentech, 1 DNA Way, South San Francisco, CA 94080, USA
3 shared publications- David W. Will
Sanofi-Aventis Deutschland GmbH, R&D, Industriepark Höchst, Building G878, 65926 Frankfurt am Main (Germany)
2 shared publications - Eugen Uhlmann
Hoechst AG, Central Pharma Research, Frankfurt/Main, Germany
2 shared publications Gerhard Breipohl
Aventis Pharma Deutschland GmbH, D-65926 Frankfurt, Germany
2 shared publicationsJean-François Gourvest
Aventis Pharma, 102 Route de Noisy, 93235 Romainville Cedex, France
2 shared publications
Latest Publications
- 6 August 2001
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (15) , 2011-2015
αvβ3 Antagonists Based on a Central Thiophene Scaffold
- 6 August 2001
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (15) , 2011-2015
αvβ3 Antagonists Based on a Central Thiophene Scaffold
- 18 August 2000
- Published by Wiley in Angewandte Chemie
- Vol. 112 (16) , 2996-2999
Vitronectin Receptor Antagonists: Purine-Based Peptidomimetics
- 18 August 2000
- Published by Wiley in Angewandte Chemie
- Vol. 112 (16) , 2996-2999
Vitronectin Receptor Antagonists: Purine-Based Peptidomimetics
- 11 August 2000
- Published by Wiley
- Vol. 39 (16) , 2874-2877
Vitronectin Receptor Antagonists: Purine-Based Peptidomimetics
- 11 August 2000
- Published by Wiley
- Vol. 39 (16) , 2874-2877
Vitronectin Receptor Antagonists: Purine-Based Peptidomimetics
- Open Access
- 1 September 1997
- Published by Wiley in European Journal of Biochemistry
- Vol. 248 (2) , 543-549
Sequence-Specific Antiproliferative Effects of Antisense and End-Capping-Modified Antisense Oligodeoxynucleotides Targeted against the 5'-Terminus of Basic-Fibroblast-Growth-Factor mRNA in Coronary Smooth Muscle Cells
- 1 September 1997
- Published by Wiley in European Journal of Biochemistry
- Vol. 248 (2) , 543-549
Open AccessSequence-Specific Antiproliferative Effects of Antisense and End-Capping-Modified Antisense Oligodeoxynucleotides Targeted against the 5'-Terminus of Basic-Fibroblast-Growth-Factor mRNA in Coronary Smooth Muscle Cells
- 22 December 1996
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 35 (22) , 2636-2638
Phosphonic Ester Nucleic Acids(PHONAs): Oligonucleotide Analogues with an Achiral Phosphonic Acid Ester Backbone
- 22 December 1996
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 35 (22) , 2636-2638
Phosphonic Ester Nucleic Acids(PHONAs): Oligonucleotide Analogues with an Achiral Phosphonic Acid Ester Backbone